Skip to content

Where do they inject in the buttocks? A Guide to Gluteal IM Sites

4 min read

Studies show that the success rates of intended intramuscular injections can vary widely, from 32% to 52%, with many injections inadvertently ending up in subcutaneous fat [1.7.2]. Knowing where do they inject in the buttocks correctly is critical for medication effectiveness and patient safety.

Quick Summary

Intramuscular injections in the gluteal region are given in two primary locations: the ventrogluteal site on the hip and the dorsogluteal site in the upper-outer buttock. The ventrogluteal site is now strongly preferred for safety.

Key Points

  • Two Main Sites: Injections in the buttocks are given in either the dorsogluteal (upper buttock) or ventrogluteal (side of hip) site [1.4.1].

  • Ventrogluteal is Safest: The ventrogluteal site is the recommended and safest location, as it is free of major nerves and blood vessels [1.6.1, 1.6.6].

  • Dorsogluteal is Risky: The dorsogluteal site carries a significant risk of injuring the sciatic nerve, which can lead to permanent pain, numbness, or foot drop [1.5.4].

  • Injection Failure: The dorsogluteal site has a high rate of failure, where the medication is injected into fat instead of muscle, reducing its effectiveness [1.5.4, 1.7.2].

  • Locating the VG Site: The ventrogluteal site is found using a 'V' shape formed by the fingers after placing the palm on the patient's hip trochanter [1.3.1].

  • Medication Types: Gluteal injections are often used for antibiotics, hormones, vaccines, and other long-acting or large-volume medications [1.8.1, 1.8.3].

  • Professional Practice: Modern healthcare guidelines strongly advocate for using the ventrogluteal site over the dorsogluteal site to improve patient safety [1.6.2, 1.6.6].

In This Article

Understanding Gluteal Intramuscular Injections

Intramuscular (IM) injections are a common method for administering medications like antibiotics, hormones, and vaccines because the muscle's rich blood supply allows for rapid absorption [1.8.2, 1.8.3]. The gluteal region, or buttocks, has traditionally been a popular choice due to its large muscle mass, which can accommodate larger volumes of medication [1.4.1]. However, not all areas of the buttock are safe for injection. Proper site selection is crucial to ensure the medication is delivered effectively into the muscle and to avoid serious complications, such as nerve damage [1.5.1, 1.6.1].

There are two distinct sites used for gluteal injections: the dorsogluteal site (the upper, outer part of the buttock) and the ventrogluteal site (located on the side of the hip) [1.4.1, 1.4.7]. While the dorsogluteal site was traditionally used, modern medical practice now strongly recommends the ventrogluteal site as the safer and more effective option [1.6.1, 1.6.6].

The Dorsogluteal (DG) Site: The Traditional but Risky Option

The dorsogluteal site is located in the gluteus maximus muscle. Healthcare providers identify this area by imagining the buttock divided into four quadrants and targeting the upper, outer quadrant [1.2.1, 1.4.2]. This method is intended to avoid the sciatic nerve, which runs through the lower and more central parts of the buttock [1.2.7].

Risks Associated with the Dorsogluteal Site: Despite its historical use, the DG site is no longer recommended by many healthcare organizations [1.4.3]. The primary danger is its close proximity to the sciatic nerve, the largest nerve in the body [1.5.4, 1.6.6]. Studies have shown the mean distance from the DG site to the sciatic nerve can be as little as 9 cm [1.6.3]. Accidental injection into or near this nerve can cause:

  • Severe and chronic pain [1.5.2]
  • Foot drop, a condition that makes it difficult to lift the front part of the foot [1.5.4]
  • Sensory loss or numbness in the leg and foot [1.5.4]
  • Paralysis in severe cases [1.5.2]

Another significant issue is the variable thickness of subcutaneous fat in this area. Many intended intramuscular injections at the DG site are mistakenly delivered only into the fat layer, especially in women and individuals with a higher BMI [1.7.2]. One study noted a failure rate as high as 43.86% in older adults, where the medication did not reach the muscle [1.5.4, 1.6.6]. This can lead to poor medication absorption, reduced effectiveness, and an increased risk of complications like abscesses and hard lumps called granulomas [1.5.4].

The Ventrogluteal (VG) Site: The Safer, Preferred Standard

In response to the risks of the DG site, the ventrogluteal site was identified as a superior alternative. Located in the gluteus medius and minimus muscles on the side of the hip, it is naturally free of major nerves and blood vessels [1.3.6, 1.6.4].

How to Locate the Ventrogluteal Site: Clinicians use a specific hand-placement technique, often called the "V method," to pinpoint the exact location [1.3.4, 1.4.1]:

  1. The patient lies on their side.
  2. The provider places the heel of their hand on the patient's greater trochanter (the bony part of the hip).
  3. The index finger is pointed toward the anterior superior iliac spine (the front of the hip crest).
  4. The middle finger is spread back along the iliac crest, forming a 'V' shape with the index finger.
  5. The injection is given in the center of that 'V' [1.3.1, 1.3.3].

This method uses clear bony landmarks, making it reliable across different body types [1.4.3]. The VG site has a thicker muscle layer and a thinner layer of subcutaneous fat compared to the DG site, which significantly increases the chance of a successful intramuscular injection [1.6.5, 1.6.6].

Comparison of Injection Sites

Feature Dorsogluteal (DG) Site Ventrogluteal (VG) Site
Location Upper-outer quadrant of the buttock [1.2.5] Side of the hip (gluteus medius/minimus) [1.4.7]
Sciatic Nerve Proximity High risk; nerve is nearby (approx. 9 cm away) [1.6.3, 1.6.6] Low risk; free of major nerves (approx. 18 cm away) [1.6.3, 1.6.6]
Success Rate Lower; high rate of injection into fat (32-52%) [1.7.2] Higher; thinner fat layer, thicker muscle [1.6.5]
Reported Pain Higher [1.5.4] Lower [1.6.4]
Risk of Complications High (nerve injury, abscess, hematoma) [1.5.4] Very low [1.6.2]
Modern Recommendation Avoid; not recommended [1.4.2, 1.5.1] Preferred site for adults and children [1.6.1, 1.6.2]

Medications Commonly Given in the Gluteal Region

The large muscle mass of the gluteal sites makes them suitable for a variety of medications, especially those that are viscous (thick) or require a larger volume [1.4.1, 1.8.6]. Common examples include:

  • Antibiotics (e.g., Penicillin G) [1.8.1, 1.8.5]
  • Hormonal agents (e.g., testosterone, medroxyprogesterone) [1.8.1, 1.8.3]
  • Vaccines and immunoglobulins [1.8.1]
  • Long-acting antipsychotics [1.8.2]
  • Vitamins (e.g., Vitamin B12) [1.8.3]

Conclusion

While the buttocks have long been a common area for injections, the specific location is critically important. The evidence is overwhelmingly clear that the ventrogluteal site (on the hip) is the safest and most effective location for gluteal intramuscular injections [1.6.6]. Its distance from the sciatic nerve and major blood vessels, combined with a more reliable muscle depth, minimizes the risk of serious complications and ensures the medication works as intended [1.6.2]. The traditional dorsogluteal site, due to its high risk of causing permanent nerve damage and injection failure, is now actively discouraged in modern clinical practice [1.4.3, 1.5.1].

For more information on injection safety, consult guidance from reputable health organizations like the World Health Organization.

[Authoritative Link Here if applicable: e.g., A link to a WHO or CDC guideline on injection safety.]


Disclaimer: This article is for informational purposes only and does not constitute medical advice. Intramuscular injections should only be administered by a qualified healthcare professional.

Frequently Asked Questions

The two primary intramuscular injection sites are the dorsogluteal site, located in the upper-outer quadrant of the buttock, and the ventrogluteal site, located on the side of the hip [1.4.1].

The ventrogluteal site is preferred because it is free from major nerves and blood vessels, has a thinner layer of fat, and a thicker muscle mass, reducing the risk of injury and ensuring the medication is properly absorbed [1.6.1, 1.6.5].

The most significant risk is accidentally hitting the sciatic nerve, which can cause severe, long-lasting complications like intense pain, foot drop, numbness, and even partial paralysis of the leg [1.5.2, 1.5.4].

To find the traditional dorsogluteal site, you imagine a cross that divides one buttock into four equal squares. The injection is given in the upper, outer square (quadrant) to avoid the sciatic nerve [1.2.1, 1.4.5].

Yes, especially in the dorsogluteal site in older adults or thin individuals, there is a risk of the needle hitting bone. Studies show this risk is virtually zero when using the preferred ventrogluteal site with standard needles [1.5.4, 1.6.6].

Yes. Individuals with more subcutaneous fat are at higher risk of the injection failing to reach the muscle, especially at the dorsogluteal site. The ventrogluteal site generally has less fat, making it a more reliable choice for people of varying BMIs [1.6.6, 1.7.2].

If medication is injected into the subcutaneous fat, its absorption will be slower and less predictable, potentially making the drug less effective. It can also increase the risk of local complications like pain, inflammation, and abscesses [1.5.4, 1.6.6].

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.